Cyclic AMP and anxiety.

No abstract is available for this paper.

• Publication year

  1972

• Venue

  Psychosomatics

• Publication date

  1972-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0033-3182(72)71443-7PMID 4368551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A simple and reliable conflict procedure for testing anti-anxiety agents

  2004cited by this paper
• Alpha- and beta-adrenergic receptors as mediators of accumulation of cyclic adenosine 3',5'-monophosphate in specific areas of guinea pig brain.

  1971cited by this paper
• Modification by spychotropic drugs of the cyclic adenosine monophosphate response to norepinephrine in rat brain.

  1971cited by this paper
• 3',5' cyclic adenosine monophosphate in depression and mania.

  1970cited by this paper
• Some properties of cyclic 3',5'-nucleotide phosphodiesterase of mouse brain: effects of imidazole-4-acetic acid, chlorpromazine, cyclic 3',5'-GMP, and other substances.

  1970cited by this paper
• Effects of chlorpromazine, propranolol and phospholipase C on thyrotropin and prostaglandin stimulation of adenyl cyclase-cyclic AMP system in dog thyroid slices.

  1970cited by this paper
• Advances in biochemical psychopharmacology: Volume 1, edited by E. Costa and P. Greengard, Raven press (1969)

  1970cited by this paper
• Inhibition of hormone-sensitive adenyl cyclase by phenothiazines.

  1970cited by this paper
• Cyclic A.M.P. in affective disorders.

  1970cited by this paper
• The effect of histamines and other compounds on the formation of adenosine 3′,5′‐monophosphate in slices from cerebral cortex

  1970cited by this paper
• CYCLIC 3',5'-NUCLEOTIDE PHOSPHODIESTERASE IN BRAIN

  1969cited by this paper
• Adenyl Cyclase and Phosphodiesterase Activities in Brain Areas of Man, Monkey and Rat

  1969cited by this paper
• Inhibition of cyclic 3',5'-nucleotide phosphodiesterase by phenothiazine and reserpine derivatives.

  1968cited by this paper
• The influence of chemical agents on the accumulation of adenosine 3',5'-Phosphate in slices of rabbit cerebellum.

  1968cited by this paper
• The assay of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate in biological materials by enzymatic radioisotopic displacement.

  1968cited by this paper
• Regional and subcellular distribution of adenyl cyclase and 3',5'-cyclic nucleotide phosphodiesterase in brain and pineal gland.

  1968cited by this paper
• A. THE ROLE OF CYCLIC-3',5'-AMP IN RESPONSES TO CATECHOLAMINES AND OTHER HORMONES

  1966cited by this paper
• THE RELATION OF ADENOSINE-3', 5'-PHOSPHATE AND PHOSPHORYLASE TO THE ACTIONS OF CATECHOLAMINES AND OTHER HORMONES

  1960cited by this paper

• Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model.

  2017cites this paper
• The Role of Protein Kinase A in Anxiety Behaviors

  2016cites this paper
• Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy

  2014cites this paper
• Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: modulation of hypothalamic-pituitary-adrenal axis activity and brain-derived neurotrophic factor level.

  2013cites this paper
• Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage.

  2013cites this paper
• Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor--an approach using rodent behavioral antidepressant tests battery.

  2012cites this paper
• Physicochemical characterization of substituted chromeno[4,3-b][1,5]benzodiazepine stereoisomers designed as cell membrane active antitumor agents

  1990cites this paper
• Chemistry of Pyrazolopyrimidines

  1988cites this paper
• Synthese von 5,7‐Diaminopyrazolo[1,5‐a]pyrimidinen

  1985cites this paper
• Etazolate (SQ20009): electrophysiology and effects on [3H]flunitrazepam binding in cultured cortical neurons

  1983cites this paper
• Psychosocial factors and psychophysiological mechanisms in the aetiology and development of cancers.

  1982cites this paper
• Inhibition by etazolate (SQ 20009) and cartazolate (SQ 65396) of adenosine-stimulated [3H]cAMP formation in [2-3H]adenine-prelabeled vesicles prepared from guinea pig cerebral cortex.

  1982cites this paper
• Stress and cancer: the state of the art. Part 2.

  1981cites this paper
• Psychoneuroendocrinological effects on the immune response.

  1981cites this paper
• Stress and cancer: the state of the art. Part 2.

  1981cites this paper
• Biochemical Effects of Anxiolytics

  1981cites this paper
• Brain Stimulation and Neurochemical Studies on the Control of Aggression

  1981cites this paper
• Hydrolysis and subsequent cyclization of etazolate hydrochloride and related compounds in aqueous solutions: application of PMR and mass spectrometry in accelerated stability studies.

  1978cites this paper
• EFFECT OF DIAZEPAM AND PENTOBARBITAL ON AMINOOXYACETIC ACID‐INDUCED ACCUMULATION OF GABA

  1977cites this paper
• 3-Halo-5,7-dimethylpyrazolo [1,5-a]pyrimidines, a nonbenzodiazepinoid class of antianxiety agents devoid of potentiation of central nervous system depressant effects of ethanol or barbiturates.

  1977cites this paper
• Role of Cyclic Nucleotides in the Nervous System

  1975cites this paper
• Cyclic nucleotides as mediators of drug action.

  1975cites this paper
• Cyclic nucleotides as mediators of drug action.

  1975cites this paper
• Inhibition of prostaglandin biosynthesis.

  1974cites this paper
• From the Symbolic Stimulus to the Pathophysiologic Response: Immune Mechanisms

  1974cites this paper
• The cyclic AMP system and drug development.

  1974cites this paper
• 6 – Chemistry and Pharmacology of the 1,4-Benzodiazepines

  1974cites this paper
• Drugs which inhibit prostaglandin biosynthesis.

  1974cites this paper
• Chapter 23. Agents Affecting Cyclic AMP Levels

  1973cites this paper
• Chapter 1. Antipsychotic and Anti-anxiety Agents

  1972cites this paper